HANYWIL-DARK SPOT

Manufacturer
Jiashen International Trading Co., Ltd.
Effective date
2024-11-10
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:36:29

Label at a glance#

ProductHANYWIL-DARK SPOT
Active ingredientALPHA-ARBUTIN, INOSITOL, 3-O-ETHYL ASCORBIC ACID, CENTELLA ASIATICA TRITERPENOIDS, NIACINAMIDE
Label structure11 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

NIACINAMIDE 1.5%/50ml
INOSITOL 1%/ml
ALPHA-ARBUTIN 0.15%/ml

CENTELLA ASIATICA EXTRACT 0.125%/ml
3-o-ETHYL ASCORBIC ACID 0.1%/ml

INACTIVE INGREDIENT SECTION

WATER
GLYCERIN
PROPYLENE GLYCOL
CAPRYLIC/CAPRIC TRIGLYCERIDE
CETEARYL ALCOHOL
CETEARYL GLUCOSIDE
DIMETHICONE 350
BUTYROSPERMUM PARKII (SHEA) BUTTER
GLYCERYL STEARATE
PORTULACA OLERACEA EXTRACT
CHRYSANTHELLUM INDICUM EXTRACT
PELARGONIUM GRAVEOLENS EXTRACT
MENTHA ARVENSIS LEAF EXTRACT
ALOE BARBADENSIS EXTRACT
SOPHORA ANGUSTIFOLIA ROOT EXTRACT
SQUALANE
TOCOPHERYL ACETATE
1,2-HEXANEDIOL
HYDROXYACETOPHENONE
PHENOXYETHANOL
ETHYLHEXYLGLYCERIN
CARBOMER
DISODIUM EDTA
FRAGRANCE

OTC - PURPOSE SECTION

DARK SPOT REMOVERFOR FACE AND BODY:Deeply hydrates the skinReduces uneven skin toneMinimizes age spots,sun spots, freckles,brown spots, etc.Firms skin, improveselasticity and firmness.

WARNINGS SECTION

WARNINGSThis product is forexternal use only andshould not come intocontact with the eyes.In case of inadvertentcontact, rinse immediatelywith water and seekmedical attention. lfyou have allergicsymptoms or skinabnormalities,pleasestop using and seekmedical advice

OTC - STOP USE SECTION

If pregnant or breast-feading, ask a heatthprofessional before use, Keep out of reach ofchildren, in case of overdose,got medical help orcontact a Poison Control Center right away.

OTC - DO NOT USE SECTION

When using this productuSwipe onto a clean face, morning and/or evening. Do not rinse. For daytime use, follow with sunscreen

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach ofchildren.In case of overdose,got medical helpor contact a Poison Control Center right away

INDICATIONS & USAGE SECTION

INSTRUCTIONS
Step 1: Wash your faceand keep it clean.
Step 2: Take an appropriateamount of dark spotcream and apply evenly to the desiredarea, massage gentlyfor 1-2 minutes.
Step 3: Use twice a day, with massage to help absorption, adhere to the use of more than a month the best results.
It is recommended to use it twice a day inthe morning andevening for both menand women.

DOSAGE & ADMINISTRATION SECTION

Take an appropriateamount of dark spotcream and apply evenly to the desiredarea, massage gentlyfor 1-2 minutes.

OTC - WHEN USING SECTION

When using this product#Swipe onto a clean face, morning and/or evening.Do not rinse.
. For daytime use, follow with sunscreen

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

package labelingpackage labeling

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84867-003-01HANYWIL-DARK SPOT50 mL in 1 BOTTLE, PLASTICCREAM501

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84867-003HANYWIL-DARK SPOT CREAM [JIASHEN INTERNATIONAL TRADING CO., LTD.]11 package rows20241111_268efcae-b539-bac7-e063-6394a90ac6bc.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 30 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84867-00384867-003-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 29 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
268efcae-b53a-bac7-e063-6394a90ac6bc268efcae-b539-bac7-e063-6394a90ac6bc2024-11-10WarningsExact identifier
spl id: 268efcae-b53a-bac7-e063-6394a90ac6bc
spl set id: 268efcae-b539-bac7-e063-6394a90ac6bc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.